MARC Record from marc_columbia

LEADER: 05537cam a2200709Ma 4500
001 15062197
005 20221008230432.0
006 m o d
007 cr cn|||||||||
008 000807s1999 nyua ob 001 0 eng d
010 $z 99026854
035 $a(OCoLC)ocm44954205
035 $a(NNC)15062197
040 $aN$T$beng$epn$cN$T$dOCL$dOCLCQ$dYDXCP$dOCLCG$dOCLCQ$dTUU$dOCLCQ$dTNF$dOCLCQ$dZCU$dOCLCO$dOCLCF$dOCLCQ$dZWZ$dIDEBK$dOCLCQ$dMWM$dOCLCO$dTOA$dOCLCO$dSUR$dOCLCQ$dSAV$dICD$dQT7$dOCLCO$dOCLCQ$dOCLCO$dOCLCA$dYDX$dOCLCO$dBUF$dOCLCO$dLUE$dOCLCO$dOCLCQ$dINT$dTOF$dOCLCQ$dJZ6$dUKAHL$dSCL$dCHBRC$dAJS$dOCLCA$dTUHNV$dOCLCA$dOCLCO
019 $a490335953$a532529102$a961676871$a962713593$a970721481$a984885665$a1007397126$a1038635826$a1049742638$a1052995092$a1135450084$a1196945500
020 $a0585157235$q(electronic bk.)
020 $a9780585157238$q(electronic bk.)
020 $a9780824719814$q(alk. paper)
020 $a0824719816$q(alk. paper)
020 $z0824719816$q(alk. paper)
035 $a(OCoLC)44954205$z(OCoLC)490335953$z(OCoLC)532529102$z(OCoLC)961676871$z(OCoLC)962713593$z(OCoLC)970721481$z(OCoLC)984885665$z(OCoLC)1007397126$z(OCoLC)1038635826$z(OCoLC)1049742638$z(OCoLC)1052995092$z(OCoLC)1135450084$z(OCoLC)1196945500
050 4 $aRS403$b.P765 1999eb
060 14 $aQV 744$bP963 2008eb
072 7 $aMED$x023000$2bisacsh
072 7 $aMED$x071000$2bisacsh
072 7 $aMED$x072000$2bisacsh
072 7 $aMED$x058170$2bisacsh
082 04 $a615/.19$221
049 $aZCUA
245 00 $aProcess chemistry in the pharmaceutical industry /$cedited by Kumar G. Gadamasetti.
260 $aNew York :$bMarcel Dekker,$c©1999.
300 $a1 online resource (xxi, 474 pages) :$billustrations
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aForeword 1 -- Foreword 2 -- The challenges of process R&D -- Preface -- Acknowledgments -- Contributors -- Overview ; 1. Process chemistry in the pharmaceutical industry: An overview -- Strategy ; 2. Process research and development strategy for accelerated projects -- Case studies ; 3. A practical synthesis of ifetroban sodium ; 4. Synthesis of 5-lipoxygenase inhibitors ; 5. Chemistry of vitamin D: A challenging field for process research ; 6. A highly optimized and concise large scale synthesis of a purine bronchodilator ; 7. Ontazolast: The evolution of a process ; 8. Dilevalol hydrochloride: Development of a commercial process ; 9. Design and development of practical synthesis of LY228729, a potent 5HT. receptor agonist ; 10. Process research and development of CGS 19755, an NMDA antagonist ; 11. Route evaluation for the production of (R)-Levoprotiline ; 12. The process research and development of Dupont Merck's cyclic urea diols, a new class of HIV protease inhibitors ; 13. Practical enantio- and diastereo-selective processes for azetidinones ; 14. Synthesis of the common lactone moiety of HMG-CoA reductase inhibitors -- Enzymatic intervention and phase transfer catalysis ; 15. Chemistry, biocatalysis and engineering: An interdisciplinary approach to the manufacture of the benzodiazepine drug candidate LY300164 ; 16. Benefits and challenges of applying phase-transfer catalysis technology in the pharmaceutical industry -- Asymmetric synthesis and enantioselectivity ; 17. Enantioselective synthesis: The optimum process ; 18. Practical catalysts for asymmetric synthesis: Ligands from natural sugars for Rh-catalyzed asymmetric synthesis of D- and L- amino acids ; 19. Chiral (salen) Mn(III) complexes in asymmetric epoxidations: Practical synthesis of cis-aminoindanol and its application to enantiopure drug synthesis -- Drug substance final form and process safety ; 20. Chemical development of the drug substance solid form ; 21. The basic principles of thermal process safety: Towards a better communication between safety experts to process chemists -- Design of experiments and automation ; 22. Using factorial experiments in the development of process chemistry ; 23. Laboratory automation in chemical development -- Author index -- Affiliation index -- Subject index.
588 0 $aPrint version record.
650 0 $aPharmaceutical chemistry.
650 0 $aChemical processes.
650 12 $aChemistry, Pharmaceutical$xmethods
650 22 $aChemistry, Analytical.
650 22 $aPharmaceutical Preparations$xanalysis
650 22 $aTechnology, Pharmaceutical$xmethods
650 2 $aChemistry, Pharmaceutical
650 6 $aChimie pharmaceutique.
650 6 $aProcédés chimiques.
650 7 $aMEDICAL$xDrug Guides.$2bisacsh
650 7 $aMEDICAL$xPharmacology.$2bisacsh
650 7 $aMEDICAL$xPharmacy.$2bisacsh
650 7 $aMEDICAL$xNursing$xPharmacology.$2bisacsh
650 7 $aChemical processes.$2fast$0(OCoLC)fst00853156
650 7 $aPharmaceutical chemistry.$2fast$0(OCoLC)fst01060115
650 7 $aChimie pharmaceutique.$2ram
650 7 $aProcédés chimiques.$2ram
650 7 $aIndustrie pharmaceutique.$2ram
655 0 $aElectronic books.
655 4 $aElectronic books.
700 1 $aGadamasetti, Kumar G.,$d1949-
776 08 $iPrint version:$tProcess chemistry in the pharmaceutical industry.$dNew York : Marcel Dekker, ©1999$z0824719816$w(DLC) 99026854$w(OCoLC)41049751
856 40 $uhttp://www.columbia.edu/cgi-bin/cul/resolve?clio15062197$zTaylor & Francis eBooks
852 8 $blweb$hEBOOKS